Insider Stock Trading History of Schreiber Alain


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Schreiber Alain since year 2005. The trader's CIK number is 1225149. At the time of this reporting, Schreiber Alain is the 10% Owner of Urogen Pharma Ltd. . (stock ticker symbol URGN). See this page for all insider trading activities at Urogen Pharma Ltd. .

Note that in the past SCHREIBER ALAIN also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Schreiber Alain since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-27 URGN Urogen Pharma Ltd. Sale 31,491 41.12 1,294,909
2017-11-28 URGN Urogen Pharma Ltd. Sale 177,807 40.51 7,202,961
2017-04-25 EGRX Eagle Pharmaceuticals, Inc. Option Ex 54,180 17.09 925,719
2017-04-25 EGRX Eagle Pharmaceuticals, Inc. Sale 54,180 88.72 4,806,578
2017-04-03 EGRX Eagle Pharmaceuticals, Inc. Sale 61,420 83.13 5,105,844
2017-03-31 EGRX Eagle Pharmaceuticals, Inc. Sale 23,689 83.02 1,966,660
2017-03-30 EGRX Eagle Pharmaceuticals, Inc. Sale 6,223 83.00 516,509
2017-03-29 EGRX Eagle Pharmaceuticals, Inc. Sale 60,855 83.01 5,051,573
2017-03-27 EGRX Eagle Pharmaceuticals, Inc. Sale 39,431 83.00 3,272,773
2017-03-28 EGRX Eagle Pharmaceuticals, Inc. Sale 6,182 83.02 513,229
2017-03-21 EGRX Eagle Pharmaceuticals, Inc. Sale 500 83.10 41,550
2017-03-23 EGRX Eagle Pharmaceuticals, Inc. Sale 700 83.01 58,107
2017-03-16 EGRX Eagle Pharmaceuticals, Inc. Sale 9,120 82.08 748,569
2017-03-20 EGRX Eagle Pharmaceuticals, Inc. Sale 51,883 82.10 4,259,594
2017-03-17 EGRX Eagle Pharmaceuticals, Inc. Sale 38,997 82.01 3,198,143
2017-01-04 EGRX Eagle Pharmaceuticals, Inc. Sale 65,114 85.16 5,545,108
2016-11-10 EGRX Eagle Pharmaceuticals, Inc. Sale 18,935 85.70 1,622,767
2016-11-11 EGRX Eagle Pharmaceuticals, Inc. Sale 15,551 85.00 1,321,835
2016-11-09 EGRX Eagle Pharmaceuticals, Inc. Sale 148,800 77.81 11,578,574
2016-11-07 EGRX Eagle Pharmaceuticals, Inc. Sale 5,030 75.39 379,211
2016-11-02 EGRX Eagle Pharmaceuticals, Inc. Sale 199,600 70.10 13,992,359
2016-11-04 EGRX Eagle Pharmaceuticals, Inc. Sale 46,170 75.00 3,462,750
2016-09-30 EGRX Eagle Pharmaceuticals, Inc. Sale 22,100 70.06 1,548,326
2016-09-29 EGRX Eagle Pharmaceuticals, Inc. Sale 77,900 70.04 5,456,116
2016-09-21 EGRX Eagle Pharmaceuticals, Inc. Sale 99,795 66.43 6,629,681
2016-09-06 EGRX Eagle Pharmaceuticals, Inc. Sale 25,397 62.84 1,595,947
2016-09-08 EGRX Eagle Pharmaceuticals, Inc. Sale 34,086 62.33 2,124,580
2016-09-07 EGRX Eagle Pharmaceuticals, Inc. Sale 11,442 62.26 712,378
2016-08-23 EGRX Eagle Pharmaceuticals, Inc. Sale 17,265 63.13 1,089,887
2016-08-24 EGRX Eagle Pharmaceuticals, Inc. Sale 11,605 62.78 728,561
2016-08-17 EGRX Eagle Pharmaceuticals, Inc. Sale 14,696 61.01 896,602
2016-08-16 EGRX Eagle Pharmaceuticals, Inc. Sale 60,150 61.22 3,682,142
2016-08-15 EGRX Eagle Pharmaceuticals, Inc. Sale 24,949 60.80 1,517,023
2015-05-12 IMDZ Immune Design Corp. Sale 177,607 21.88 3,886,041
2015-04-22 IMDZ Immune Design Corp. Sale 25,249 26.56 670,613
2015-04-23 IMDZ Immune Design Corp. Sale 32,643 27.00 881,197
2015-04-24 IMDZ Immune Design Corp. Sale 25,000 26.64 666,000
2015-04-17 IMDZ Immune Design Corp. Sale 18,861 26.67 503,022
2015-04-20 IMDZ Immune Design Corp. Sale 12,792 26.44 338,220
2015-04-21 IMDZ Immune Design Corp. Sale 14,167 26.35 373,300
2015-04-14 IMDZ Immune Design Corp. Sale 13,814 27.26 376,569
2015-04-15 IMDZ Immune Design Corp. Sale 40,000 28.87 1,154,800
2015-04-16 IMDZ Immune Design Corp. Sale 100 26.75 2,675
2015-04-06 IMDZ Immune Design Corp. Sale 3,895 26.88 104,697
2015-04-07 IMDZ Immune Design Corp. Sale 3,600 26.55 95,580
2015-04-01 IMDZ Immune Design Corp. Sale 62,454 26.38 1,647,349
2015-03-24 IMDZ Immune Design Corp. Sale 13,200 27.67 365,244
2015-03-25 IMDZ Immune Design Corp. Sale 4,956 27.56 136,587
2015-03-23 IMDZ Immune Design Corp. Sale 5,000 27.78 138,900
2015-03-19 IMDZ Immune Design Corp. Sale 30,000 27.81 834,300
2015-03-20 IMDZ Immune Design Corp. Sale 9,464 27.88 263,837
2015-03-16 IMDZ Immune Design Corp. Sale 10,309 25.43 262,157
2015-03-17 IMDZ Immune Design Corp. Sale 20,000 25.94 518,800
2015-03-18 IMDZ Immune Design Corp. Sale 20,000 26.90 538,040
2015-03-11 IMDZ Immune Design Corp. Sale 29,000 25.02 725,580
2015-03-12 IMDZ Immune Design Corp. Sale 94,199 24.94 2,349,323
2015-03-10 IMDZ Immune Design Corp. Sale 6,143 24.65 151,424
2015-03-09 IMDZ Immune Design Corp. Sale 32,300 25.61 827,203
2015-03-06 IMDZ Immune Design Corp. Sale 1,146 25.01 28,661
2015-03-05 IMDZ Immune Design Corp. Sale 6,000 24.65 147,900
2014-02-18 EGRX Eagle Pharmaceuticals, Inc. Buy 333,333 15.00 4,999,995
2009-10-12 AVNR Avanir Pharmaceuticals Sale 427,145 2.12 905,547
2009-10-09 AVNR Avanir Pharmaceuticals Sale 804,712 2.46 1,979,591
2009-10-13 AVNR Avanir Pharmaceuticals Sale 547,135 2.23 1,220,111
2009-08-11 AVNR Avanir Pharmaceuticals Sale 894,120 3.58 3,200,949
2009-03-04 OPTR Optimer Pharmaceuticals Inc Buy 457,666 .00 0
2008-10-22 AVNR Avanir Pharmaceuticals Buy 10,600 .48 5,088
2008-10-14 AVNR Avanir Pharmaceuticals Buy 32,300 .50 16,150
2008-10-15 AVNR Avanir Pharmaceuticals Buy 6,465 .49 3,167
2008-10-10 AVNR Avanir Pharmaceuticals Buy 73,551 .45 33,097
2008-10-07 AVNR Avanir Pharmaceuticals Buy 21,318 .48 10,232
2008-10-08 AVNR Avanir Pharmaceuticals Buy 114,384 .50 57,192
2008-10-09 AVNR Avanir Pharmaceuticals Buy 41,385 .48 19,864
2008-09-17 AVNR Avanir Pharmaceuticals Buy 413,217 .80 330,573
2008-09-16 AVNR Avanir Pharmaceuticals Buy 17,387 .76 13,214
2008-09-15 AVNR Avanir Pharmaceuticals Buy 244,449 .85 207,781
2008-09-08 AVNR Avanir Pharmaceuticals Buy 125,000 .95 118,750
2008-09-09 AVNR Avanir Pharmaceuticals Buy 146,400 .92 134,688
2008-09-10 AVNR Avanir Pharmaceuticals Buy 48,103 .91 43,773
2008-09-03 AVNR Avanir Pharmaceuticals Buy 6,864 .93 6,383
2008-09-02 AVNR Avanir Pharmaceuticals Buy 323,550 .93 300,901
2008-09-04 AVNR Avanir Pharmaceuticals Buy 52,113 .95 49,507
2008-08-27 AVNR Avanir Pharmaceuticals Buy 89,447 .95 84,974
2008-08-14 AVNR Avanir Pharmaceuticals Buy 6,051 .90 5,445
2008-08-15 AVNR Avanir Pharmaceuticals Buy 114,032 .95 108,330
2008-08-07 AVNR Avanir Pharmaceuticals Buy 91,380 .98 89,552
2008-08-07 AVNR Avanir Pharmaceuticals Buy 91,380 .98 89,552
2008-08-06 AVNR Avanir Pharmaceuticals Buy 400 .90 360
2008-08-06 AVNR Avanir Pharmaceuticals Buy 400 .90 360
2008-07-18 OPTR Optimer Pharmaceuticals Inc Buy 943,396 8.48 7,999,998
2007-09-18 CADX Cadence Pharmaceuticals Inc Sale 7,900 13.50 106,650
2007-09-17 CADX Cadence Pharmaceuticals Inc Sale 200 13.50 2,700
2007-09-19 CADX Cadence Pharmaceuticals Inc Sale 74,300 13.99 1,039,679
2007-09-19 CADX Cadence Pharmaceuticals Inc Sale 28,800 14.33 412,704
2007-09-12 CADX Cadence Pharmaceuticals Inc Sale 2,500 13.63 34,082
2007-09-14 CADX Cadence Pharmaceuticals Inc Sale 500 13.50 6,750
2007-01-05 NVD Novadel Pharma Inc Buy 961,914 1.45 1,394,775
2006-04-12 NVD Novadel Pharma Inc Buy 689,656 1.45 1,000,001
2005-11-29 PTN Palatin Technologies Inc Sale 358,000 3.92 1,405,150
2005-10-28 THLD Threshold Pharmaceuticals Inc Sale 110,364 10.46 1,154,407

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schreiber Alain (10% Owner of Urogen Pharma Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.